Gardas A, Rives K L
Acta Endocrinol (Copenh). 1986 Oct;113(2):255-60. doi: 10.1530/acta.0.1130255.
A sensitive and specific enzyme-linked immunosorbent assay (ELISA) for the detection of autoantibodies reacting with thyroid plasma membrane antigens has been established. Autoantibodies reacting with thyroid plasma membrane antigens were detected by the ELISA in 95% of untreated hyperthyroid Graves', 68% of antithyroid drug-treated Graves' up to four months of the therapy, in 62% of Hashimoto's thyroiditis and in 8.9% of toxic nodular goitre. The ELISA was negative in 100% healthy blood donors, 100% non-toxic nodular goitre, in 12 patients with rheumatoid arthritis, 18 patients with scleroderma and 94% of patients with systemic lupus erythematosus. The mean value of autoantibodies titre was higher in untreated hyperthyroid Graves' (1:84,000) and lowest in positive patients with autoimmune disease of non-thyroid origin (1:4000). The cross-reactivity of antimicrosomal antigen antibodies was below 10%; there was no influence of antithyroglobulin antibodies on the ELISA; and most of the autoantibodies react with plasma membrane antigens different from the TSH binding sites.
已建立一种灵敏且特异的酶联免疫吸附测定(ELISA)法,用于检测与甲状腺质膜抗原发生反应的自身抗体。通过ELISA法,在95%未经治疗的甲状腺功能亢进型格雷夫斯病患者、68%接受抗甲状腺药物治疗达四个月的格雷夫斯病患者、62%桥本甲状腺炎患者以及8.9%毒性结节性甲状腺肿患者中检测到了与甲状腺质膜抗原发生反应的自身抗体。在100%的健康献血者、100%的非毒性结节性甲状腺肿患者、12例类风湿性关节炎患者、18例硬皮病患者以及94%的系统性红斑狼疮患者中,ELISA检测结果均为阴性。未经治疗的甲状腺功能亢进型格雷夫斯病患者自身抗体滴度的平均值最高(1:84,000),非甲状腺源性自身免疫性疾病阳性患者的自身抗体滴度平均值最低(1:4000)。抗微粒体抗原抗体的交叉反应率低于10%;抗甲状腺球蛋白抗体对ELISA检测无影响;并且大多数自身抗体与不同于促甲状腺激素结合位点的质膜抗原发生反应。